List of insiders holdings for CATALYST PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BIOMARIN PHARMACEUTICAL INC 10% Owner | 2012-12-12 19:21:37 | 6,666,667 0 | 6,666,667 | Form 4 |
| 2 | MCENANY PATRICK J Chairman of Board of Directors | 2025-06-10 17:00:43 | 4,281,702 0 | 4,281,702 | Form 4 |
| 3 | Miller Steve Chief Op. & Scientific Officer | 2025-02-19 17:00:28 | 2,474,172 0 | 2,474,172 | Form 4 |
| 4 | Elsbernd Brian Chief Compliance/Legal Officer | 2025-03-05 17:00:39 | 2,259,987 0 | 2,259,987 | Form 4 |
| 5 | HUCKEL HUBERT E MD Director | 2014-10-06 16:29:56 | 1,963,974 0 | 1,963,974 | Form 4 |
| 6 | BRENNAN DANIEL Chief Commercial Officer | 2019-12-04 17:19:25 | 1,338,000 0 | 1,338,000 | Form 4 |
| 7 | GRANDE ALICIA VP, Treasurer and CFO | 2023-12-29 17:00:16 | 1,242,981 0 | 1,242,981 | Form 4 |
| 8 | INGENITO GARY Chief Med. & Reg. Officer | 2025-05-15 17:00:41 | 1,205,437 0 | 1,205,437 | Form 4 |
| 9 | O'Keeffe Charles B Director | 2025-02-19 17:00:20 | 940,744 0 | 940,744 | Form 4 |
| 10 | Merrigan Paul J Chief Commercial Officer | 2016-01-04 16:36:15 | 750,000 0 | 750,000 | Form 4 |
| 11 | DENKHAUS DONALD A Director | 2025-02-19 17:00:30 | 653,353 0 | 653,353 | Form 4 |
| 12 | Tierney David S Director | 2025-02-19 17:00:31 | 563,894 0 | 563,894 | Form 4 |
| 13 | Kalb Michael Wayne Executive Vice President & CFO | 2025-01-03 17:00:30 | 479,896 0 | 479,896 | Form 4 |
| 14 | COELHO PHILIP H Director | 2023-05-05 17:00:24 | 465,387 0 | 465,387 | Form 4 |
| 15 | Winship M Douglas VP, Regulatory Operations | 2015-11-05 11:26:20 | 371,631 0 | 371,631 | Form 4 |
| 16 | WALLACE MILTON J Director | 2012-12-14 17:00:46 | 286,000 0 | 286,000 | Form 4 |
| 17 | Daly Richard J President and CEO | 2025-06-03 17:00:35 | 199,764 0 | 199,764 | Form 4 |
| 18 | Andrews William T. Chief Medical Officer | 2025-06-06 17:00:46 | 139,708 0 | 139,708 | Form 3 |
| 19 | Harper Molly Director | 2025-02-19 17:00:27 | 134,020 0 | 134,020 | Form 4 |
| 20 | Rieger Richard VP Commercial Operations | 2011-11-22 17:01:01 | 100,000 0 | 100,000 | Form 3 |
| 21 | Thompson Tamar Director | 2024-12-11 17:00:27 | 99,853 0 | 99,853 | Form 4 |
| 22 | Russo Gregg Chief HR Officer | 2025-02-28 17:40:23 | 45,745 0 | 45,745 | Form 3/A |
| 23 | MUTH DAVID D EVP, Chief Commercial Officer | 2015-05-01 16:13:28 | 44,700 0 | 44,700 | Form 4 |
| 24 | Sundaram Preethi Chief Strategy Officer | 2025-06-12 17:00:42 | 41,081 0 | 41,081 | Form 4 |
| 25 | Weinstein Jack V.P., Treasurer & CFO | 2010-12-21 20:02:57 | 14,493 0 | 14,493 | Form 4 |
| 26 | Del Carmen Jeffrey Chief Commercial Officer | 2025-03-05 17:00:24 | 0 0 | 0 | Form 4 |